| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELL BIOPHYSICS |
1 University of Wisconsin-Madison
* To whom correspondence should be addressed. E-mail: jwalker{at}physiology.wisc.edu.
Submitted on August 8, 2007
Revised on September 19, 2007
Accepted on 7 March 2008
| Abstract |
|---|
30s) reduced FRET by >50%, but did not detectably reduce co-immunoprecipitation. ET-1 stimulated a transient increase in intracellular Ca2+ ([Ca2+]i) lasting 1-2 minutes for both homodimer pairs, and these ET-1 actions on FRET and [Ca2+]i elevation were blocked by the appropriate subtype selective antagonist. In contrast, ETA:ETB heterodimers mediated a sustained [Ca2+]i increase lasting >10 min, and required a combination of ETA and ETB antagonists to block the observed FRET and [Ca2+]i responses. The sensitive CFP/FlAsH FRET assay used here provides new insights into endothelin receptor dimer function, and represents a unique approach to characterize G protein-coupled receptor oligomers including their pharmacology.
Key Words: FlAsH, GPCR, co-immunoprecipitation, heterodimers
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |